GoodRx Holdings, Inc. Cash Flow Statement
GDRX / Information Technology|8 years of annual SEC 10-K data (FY2018-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 8 fiscal years. All figures from audited SEC 10-K filings.
GoodRx Holdings, Inc. generated $168M in operating cash flow and $164M in free cash flow in FY2025. Free cash flow margin was 20.6% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $30.4M | $16.4M | -$8.9M | -$32.8M | -$25.3M | -$293.6M | $66.0M | $43.8M |
| Depreciation & Amortization | $85.2M | $69.5M | $107.7M | $54.2M | $34.5M | $18.4M | $13.6M | $9.8M |
| Operating Cash Flow | $167.9M | $183.9M | $138.3M | $146.8M | $178.8M | $131.3M | $83.3M | $45.3M |
| Capital Expenditures | $3.5M | $1.2M | $1.0M | $4.0M | $4.6M | $20.6M | $1.4M | $804.0K |
| Free Cash Flow | $164.4M | $182.7M | $137.2M | $142.8M | $174.2M | $110.8M | $81.9M | $44.4M |
| Share Buybacks | $216.4M | $158.8M | $104.0M | $101.7M | $0 | $0 | - | - |
| Dividends Paid | - | - | - | - | - | - | - | $1.3B |
| FCF Margin | 20.6% | 23.1% | 18.3% | 18.6% | 23.4% | 20.1% | 21.1% | 17.8% |